Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status

BACKGROUND: Amifostine is an efficient cytoprotector against toxicity caused by some chemotherapeutic drugs. Doxorubicin, a potent anticancer anthracycline, is known to produce spermatogenic damage even in low doses. Although some studies have suggested that amifostine does not confer protection to...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendramini, Vanessa, Sasso-Cerri, Estela, Miraglia, Sandra M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832784/
https://www.ncbi.nlm.nih.gov/pubmed/20064221
http://dx.doi.org/10.1186/1477-7827-8-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832784/
https://www.ncbi.nlm.nih.gov/pubmed/20064221
http://dx.doi.org/10.1186/1477-7827-8-3

Ejemplares similares